Experiences with CEPHAGRAINE in the Treatment of Headache with Special Reference to Migraine.

Similar documents
Septilin in Otolaryngology

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic

Efficacy and Clinical Assessment of Varmam Theraphy in the Management of Headache

Key words: Migraine, Nasya, Mig 17, Shirahshoola, Nasal Drop, Quick Relief

Headache Assessment In Primary Eye Care

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

PATIENT INFORMATION FORM (WOMEN ONLY)

Ketorolac injection. Supportive care

AAYUSHI INTERNATIONAL INTERDISCIPLINARY RESEARCH JOURNAL (AIIRJ)

Background. Background. Headache Examination. Headache History. Primary vs. Secondary Headaches. Headaches In Children: Why Worry?

EDITORIAL FOR THE MONTH OF MARCH 2010 COMMON E.N.T. PROBLEMS IN MY PRACTICE. Most common problems that I have encountered in my practice are:

IMPORTANT POINTS ABOUT MEDICATIONS

Treatment of Upper Respiratory Infections with Septilin

SLEEP AIDS - LABELLING STANDARD

Azelastine Nasal Spray 1 mg / 1 ml

PATIENT INFORMATION LEAFLET DYNARB RANGE

Pain therapeutics. Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain

9/18/2018. Disclosures. Objectives

Editorial for the month of October Disorders of the throat and homoeopathy

PAEDIATRIC ACUTE CARE GUIDELINE. Headache. This document should be read in conjunction with this DISCLAIMER

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

Flu is a more severe form of what people generally associate with as Cough, Cold and Fever and symptoms are usually incapacitating.

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Congestion, headache, recurrent infection, post-nasal drip, smell problems? We can find the source and offer solutions for relief.

Shodhana of Gandhaka (Sulphur) with Bhringaraj (Eclipta Alba) and Goghruta (Cow s Ghee)

Headache. Karen Thaxter

How to spot allergies. What are allergies? What can your patients do about allergies? How allergies cause sinusitis. Module 5 Allergies

Shiatsu Intake Form PURCHASED PRODUCT/SERVICE. Date of Birth Age Height Weight. Home Address City State ZIP

Voice. What is voice? Why is voice important?

patient group direction

ANVESHANA EFFECT OF ARAGVADHA PATRA KALKA AND ARNALA LEPA WITH AND WITHOUT CHAKRAMARDA SEED POWDER IN DADRU

On a scale of 1 10 ("10" being optimal health) please rate where you feel your health is in the the areas below:

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

European PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam

What causes abnormal secretions?

Suspected neurological conditions: clinical questions

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

Intelligence Development

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

I understand that as a patient, I have both rights and responsibilities. I have received a copy of this document for my reference.

Drug Utilization Pattern in Rhinittis in Outpatient Department of Government Medical College and C.P.R. Hospital, Kolhapur

ISSN: CASE STUDY OF GREEVA

Chronic Sinusitis. Acute Sinusitis. Sinusitis. Anatomy of the Paranasal Sinuses. Sinusitis. Medical Topics - Sinusitis

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

HIGHLANDS SURGERY NEWSLETTER

MANAGEMENT OF RHINOSINUSITIS IN ADOLESCENTS AND ADULTS

Metoclopramide hydrochloride mg (Quantity corresponding to anhydrous metoclopramide hydrochloride) mg

Drug Utilization Pattern in Upper Respiratory Tract Infection in Outpatient Department of Government Medical College and C.P.R. Hospital, Kolhapur

Paediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition

World Journal of Pharmaceutical Research SJIF Impact Factor 7.523

Comprehensive History, Consult, and Evaluation Form

VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology VI.2.2 Summary of treatment benefits

Use of abatacept in rheumatoid arthritis - patient information

Nature s Retreat Holistic Therapy

WILLIAM B. COBB, M.D. KEITH MATHENY, M.D. EWEN TSENG, M.D. KENNY CARTER, M.D.

European Medicines Agency recommends changes to the use of metoclopramide

Honey and Cinnamon Interesting Drug Combination!!!

florida child neurology

It is very common to get symptoms like cough, sore throat, runny nose and watery eyes. Usually when you

Oil Of The Month ALLERGY AWARENESS MAY 2018

Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine

Package Leaflet: Information for the User. Read all of this leaflet carefully because it contains important information for you.

SANDOMIGRAN (pizotifen malate)

Pituitary Tumour Surgery. Remember to bring this handout to the hospital with you.

HEADACHES THE RED FLAGS

C o u g h s n e e z i n g h o t f l a s r u n n y n o

Final report. on clinical approbation of device. BIOMEDIS-M of Ltd RPC BIOMEDIS (Moscow)

What are the causes of nasal congestion?

See Important Reminder at the end of this policy for important regulatory and legal information.

Package leaflet: Information for the patient. ROBAXIN mg Film-coated tablets for oral use Methocarbamol. 100 Tablets

AVIOMARIN 50 mg tablets

PHARMACY ACTION COLD & FLU DAY & NIGHT paracetamol, pseudoephedrine hydrochloride, chlorphenamine maleate

Ear, Nose, and Throat Disorders

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

Version Number: 5. Patient Group Direction drawn up by: Chief Pharmacist - Strategy. Group direction authorised by:

Is your cold, sore throat, earache or cough getting you down?

Drug proving as I witnessed

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

Sore throat lower back pain headache chills

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 4 January 2012

Transparency Committee Opinion 8 January 2014

Non-prescription pain relievers

DIVALPROEX (di val pro ex) SODIUM DELAYED-RELEASE TABLETS, USP

JOHN MICHAEL ROACH, MD

Initial Consultation

Smoking cessation therapy

ONZETRA XSAIL (sumatriptan) nasal powder

A Winter Free of Cold Understanding the Common Cold and Flu. Camille Aizarani, MD Family Medicine Specialist

Relief from. Snoring and Sleep Apnoea. Workbook. Tess Graham

Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets

Do you suffer from Headaches? - November/Dec 2011

PATIENT INFORMATION LEAFLET PEARINDA PLUS

A clinical study on the role of herbal compound belfaladi churna in the management of atisaar

Diabetes and Heart Disease Awareness. Washington Newsletter Fall 2011

Syncope and Seizure Questionnaire

PATIENT INFORMATION LEAFLET CARVETREND RANGE

Heart Healthy Living Tips

patient group direction

National Hospital for Neurology and Neurosurgery

Transcription:

Reprinted from The Medicine & Surgery Vol XXV No.5 May, 1985 (p.p.19,20,21) * Experiences with CEPHAGRAINE in the Treatment of Headache with Special Reference to Migraine. By Dr. Pramod Kumar, B.I.M.S., D. Ay.M., Ph.D. Professor Shalakya (E.N.T. Eye) Government Ayurvedic College, LUCKNOW. Dr. Kumud Bansal B.A.M.S. House Officer. * THE MEDICINE & SURGERY A Monthly Medical and Surgical Journal Sayajiganj, BARODA-390 005 INDIA 1

Experiences with CEPHAGRAINE in the Treatment of Headache with Special Reference to Migraine. By Dr. Pramod Kumar, B.I.M.S., D. Ay.M., Ph.D. Professor Shalakya (E.N.T. Eye) Government Ayurvedic College, LUCKNOW. Dr. Kumud Bansal B.A.M.S. House Officer. Introduction: Headache is quite common and is of minor significance in a majority of cases but of great importance in some. On the other hand headache may be a main symptom is some grave diseases. The mode of incidence of a headache is yet not easily understood though it is generally considered that the tension of the walls of cerebral blood vessels is a contributing factor in the production of a headache. The causes of headache may be divided into three main groups: - (a) Local organic diseases of the brain, intracranial vessels, meninges, skull and special organs such as eyes, ears nose, throat, etc. (b) Toxic states; (c) Functional conditions such as migraine, psychoses and other ailments. Migraine is defined as a paroxysmal intensive pain in the head preceded or accompanied by characteristic sensory or motor disturbances, or both, with vasomotor and psychic phenomena. The attack is probably the result of functional vaso motor disturbances in the intracranial branches of the carotid artery. The aetiology is unknown. Treatment of headache depends largely on finding out the causative factors. If not, symptomatic treatment is all that a general practitioner can offer since his diagnostic facilities and time are limited. A large number of analgesics singly or in combination with antihistaminic and sedative are used. However, such drugs are not without side effects. We were therefore in search of an effective safe drug and decided to evaluate an Ayurvedic formulation-cephagraine tablets and nasal drops manufactured by M/s. Charak Pharmaceuticals. The formulations are based on Ayurvedic therapy of SHIROGA, SHIRAS SHOOL. 2

Materials & Methods Cases of headache from Shalakya OPD of the Rishikul Government Ayurvedic Hospital, Hardwar, were studied in the year 1983. They were examined after obtaining a detailed history of the illness. After investigation, cases with definite cause or causes of headache were excluded from this study, leaving us with 20 cases having symptoms of migraine. TABLE I (Ages): Serial No. Age in years Number Percentage 1. 10 to 20 1 5 2. 21 to 30 15 75 3. 31 to 40 2 10 4. 41 to 50 1 5 5. 51 and above 1 5 20 100 TABLE II (Sex) Males 12 Females 8 20 TABLE III (Duration of illness): 1. less than a month 2 2. 1 to 12 months 5 3. 1 to 10 years 8 4. Over 10 years 5 TABLE IV ( Symptoms): 1. Headache (including 6 cases of migraine) 20 2. Vertigo 10 3. Nausea/Vomiting 4 TABLE V (Signs): 1. Nasal Polyp 1 3

2. Sinusitis 1 3. Chronic Tonsillitis 1 Dosage & Observation: All the patients were administered CEPHAGRAINE Tablet in a dose of two tablets three times a day for a week along with two drops in each nostril twice a day with specific instructions that the first dose by taken on an empty stomach in the morning. They were asked to avoid cold drinks, sour foods, pickles, etc Recheck and review at the end of the first week showed 3 cases with complete relief, 9 partial relief and 8 without benefit. With the second course for a week, in the remaining 17 cases 7 cases showed complete relief, 7 partial relief and 3 no relief. With the third course of a week in the remaining 10 cases complete relief was found in 3, partial in 6 and non-in 1. Cases Treated Complete relief Partial Relief No Benefit I Week 20 3 9 8 II Week 17 7 7 3 III Week 10 3 6 1 13(65%) 6(30%) 1(5%) No side effect was noticed in any of our cases. There was no sign of relapse in our series during the period of observation. Out of the six cases of migraine there was complete relief in four (66-67%) partial relief in one (17%) Discussion: Headache is a common symptom observed in day-to-day practice by general practitioners. Analgesics-anti-histaminic and sedatives are commonly prescribed or dispensed in various combinations with relief in a majority of cases where the headache is due to fever, fatigue, insomnia, indigestion, hypertension or strain etc. Cases not responding to treatment are subjected to detailed investigations and treated according to findings. However, there still exist a number of cases of chronic headache where no definite cause can be established except for stress, worry, and emotional upset to be grouped as psychosomatic or hypersensitive cases. Such cases are often labeled as a migrainous type where existing therapy is neither useful anymore nor free from troublesome side effects. 4

We treated 20 such cases, which resulted in complete relief in 13, partial in 6 and none in 1 after a three weeks course of CEPHARAINE tablets and nasal drops without any side effect. Summary and Conclusion: 20 cases of headache without evident cause were treated with an indigenous drug CEPHAGRAINE. Tablets orally in a dose of two tablets three times a day. Weekly checks revealed complete relief in 13 (65%) cases, partial relief in 6(30%) with 3 courses lasting for 3 weeks without any relapse or side effect. In our opinion CEPHARAINE tablets and nasal drops are valuable additions in the treatment of migrainous headache especially of unknown aetiology. Acknowledgements: Our thanks are due to: 1. Dr. S. O. Gupta, Director Ayurved U.P. for permission to conduct this study. 2. Dr. J. B. Sharma, Principal/Superintendent, Rishikul Government Ayurvedic College and Hospital, for his valuable guidance. 3. M/s. Charak Pharmaceuticals, Bombay, for a liberal supply of drugs for this trial References: 1. French s Index of differential diagnosis Ed. By F. Dudleyhart, X edition K.M. Verghese Co., Bombay, 1973. 2. Hand Book of Medical treatment Ed. By Milton J. Chetton Sheldon Margan, Henzy Brainered, VII edition, Lauge Medical Publicatations, Los Altes California, 1960 3. Sushruta Samhita commendted by Jaidev-Vaidyalankar Motilal Banarasi Lal, Varanasi. 4. Text book of medicine Ed. By Sir John Conybere & W. H. Naun XIII Ed. E. S. Livingstone Ltd., Lond 1961 5. Gupta s.p., Current Medical Practice, Vol.23, No.8 6. Human Physiology by C. chatterjee VIII ED. April, 1972, New Central Book Agencies, Calcutta. 7. D. K. M. Nadkarni s Indian Materia Medica, III Edition, 1976, Popular Prakashan, Bombay. 8. Chopra s Indigenous Drugs of India, II Edition, 1958, U.N.Dhur and Sons, Calcutta. 5